You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 201491 - 201500 of 205043 results
  1. Mobile Intelligent Router

    SBC: BLUETRONIX, INC.            Topic: N/A

    The communication requirements for military forces in the future will demand small, lightweight, low-powered data routers for ground troops autonomous and semi-autonomous vehicles and other applications requiring interconnected nodes. The MobileIntelligent Router (MIR) provides a solution delivers complete, secure and scalable internetworking for military systems such as Future Combat Systems that ...

    SBIR Phase I 2003 Department of DefenseDefense Advanced Research Projects Agency
  2. Front-end Controller for an Intelligent Synthetic Forces Simulation Engine

    SBC: BMH ASSOC., INC.            Topic: N/A

    The US Navy?fs Battle Force Tactical Training (BFTT) system is currently being deployed aboard US Navy surface combatant ships to provide coordinated, realistic, proficiency training. In the current implementation, the fidelity of the model representationsis not sufficient to achieve all training objectives. Additionally, the constituents of the synthetic battlespace and their behaviors are based ...

    SBIR Phase I 2003 Department of DefenseNavy
  3. N/A

    SBC: BOCK TO THE FUTURE, INC            Topic: N/A

    N/A

    SBIR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health
  4. N/A

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: N/A

    N/A

    SBIR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health
  5. N/A

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: N/A

    N/A

    SBIR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health
  6. N/A

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: N/A

    N/A

    SBIR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health
  7. LONG-ACTING GM-CSF PROTEINS FOR TREATING NEUTROPENIA

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: N/A

    DESCRIPTION: (Investigator's abstract) Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) is a cytokine that stimulates proliferation and differentiation of hematopoietic progenitor cells. Recombinant human GM-CSF is used to stimulate neutrophil production in patients with neutropenia resulting from myelosuppressive chemotherapy. Recombinant human GMCSF ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  8. LONG ACTING GCSF PROTEINS FOR TREATING NEUTROPENIA

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: N/A

    DESCRIPTION: This is a Phase II grant application to further develop long acting G-CSF proteins for the treatment of neutropenia. It is submitted by Bolder Biotechnology, Inc. George N. Cox, PhD, Principal investigator. The investigator notes the recombinant G-CSF has a worldwide ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  9. CYTOKINE CONJUGATES FOR TREATING THROMBOCYTOPENIA

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: N/A

    DESCRIPTION (provided by applicant): Most human protein therapeutics require frequent dosing due to rapid clearance of the proteins from the body. Development of second generation protein pharmaceuticals that can be injected less frequently is of considerable interest to patients and healthcare providers. We propose to create long-acting forms of IL-11 and TPO by creating larger versions of these ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  10. Long-Acting IL-11 for Treating Thrombocytopenia

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: N/A

    DESCRIPTION (provided by applicant): Interleukin 11 (IL-11) is a cytokine that stimulates proliferation, maturation and functional activation of platelets. Recombinant human IL- 11 is approved and marketed as a treatment for thrombocytopenia in certain patients undergoing myelosuppressive cancer chemotherapy, the market for which is estimated to be $500 million. IL-11 has a short in vivo half-life ...

    SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government